Current Clinical Trials

Every treatment, medication, and procedure available today was once tested as part of a clinical trial. These carefully designed scientific studies are among the last steps in the research process, helping doctors continually improve care. The primary goal of clinical trials is to advance medicine by finding better ways to treat and prevent disease. Clinical trials are available through the Clinical Trials Office and McGlinn Cancer Institute.

We have several open clinical trials that can be reviewed below.

Cardiology

Heart Failure

REHAB-HF

"A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients"

Investigator: Jared Green, DO

The purpose of this study is to measure the effect of an exercising training program has on physical function, hospital readmission rates and medical costs for people admitted to the hospital with a diagnosis of heart failure.

Learn more about the REHAB-HF trial or call the Clinical Trials Office at 484-628-8585.

CardioMEMS

CardioMEMS Heart Failure System Post Approval Study

Investigator: Jared Green, DO

The purpose of this post-approval study is to educate the use of the CardioMEMS Heart Failure system in qualifying subjects to confirm its safety and effectiveness.

Learn more about the CardioMEMS trial or call the Clinical Trials Office at 484-628-8585.

Colonoscopy

Colon Cancer Screening

Biofilm Epidemiology and Mechanisms of Colon Cancer

Investigators: Louis LaLuna, MD; John Altomare, MD; Ravi Ghanta, MD; Christopher Ibrahim, MD; Nirav Shah, MD

This research is being done to learn more about why people get colon cancer. We are looking to identify specific bacteria in the colon that may be linked to the development of colon cancer, and small biopsies will be taken along with other samples to look for these bacteria.

Learn more about the colonoscopy trial or call the Clinical Trials Office at 484-628-8585.

Emergency Medicine

Pulmonary Embolism

MERCURY PE

MultiEnter Trial of Rivaroxaban for Early DisCharge of PUlmonaRY Embolism from the Emergency DepartmentInvestigator: John Derderian, DO

Investigator: John Derderian, DO

The purpose of this study is to evaluate the safety of discharging low-risk Pulmonary Embolism (a condition in which one or more arteries in the lungs become blocked by a blood clot) subjects from the Emergency Department on the medication rivaroxaban.

Learn more about the MERCURY PE trial or call the Clinical Trials Office at 484-628-8585.

Anticoagulants and Bleeding

SOAR

Safety of Oral Anticoagulants Registry: A National, Hospital-based Sentinel Surveillance Study of the Clinical and Economic Impact of Bleeding and Bleeding Concerns due to the use of Oral Anticoagulants

Investigator: Adam Sigal, MD

This is a registry study to identify the clinical and economic impact of safety concerns around the use of oral anticoagulants, the evaluation and management in an emergency department or on inpatient units. The data is used to improve approaches to the management and development of a new protocol safety standard.

Learn more about the SOAR trial or call the Clinical Trials Office at 484-628-8585.

Endocrinology and Diabetes

Prediabetes

Sweetch

Effectiveness of a Smartphone-Assisted Coaching System to Improve Glucose Homeostasis in Adults with Prediabetes

Investigator: Brian Kane, MD

The purpose of this study is to test the usefulness of Sweetch, a personalized mobile-health platform coaching system (mobile phone app) designed to promote adherence to physical activity guidelines for people with prediabetes.

Learn more about the Sweetch trial or call the Clinical Trials Office at 484-628-8585.

Infectious Disease

Clostridium difficile

Cdiffense

Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile Infection

Investigator: Robert Jones, DO

This study is recruiting patients who are age 50 or older and planning an upcoming hospitalization of more than 72 hours for a surgical procedure OR who have had at least two hospital stays and have received antibiotics in the past year.

Learn more about the Cdiffense trial or call the Clinical Trials Office at 484-628-8585.

HIV

Egrifta

A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects with HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (tesamorelin for injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®

Investigator: Robert Jones, DO

This study is a long-term observational study comparing subjects with HIV-associated belly fat who take the medicine, EGRIFTA with subjects of a similar group that haven's taken Egrifta.

Learn more about the Egrifta trial or call the Clinical Trials Office at 484-628-8585.

Neurology

Alzheimer's Disease

DIADS

Venlafaxine for Depression in Alzheimer's Disease

Investigator: Kolin Good, MD

The purpose of this study is to test the use of the medication venlafaxine to treat depression in Alzheimer's Disease.

Learn more about the DIADS trial or call the Clinical Trials Office at 484-628-8585.

Stroke

ARAMIS

Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke Registry

Investigator: Karen Hoerst, MD

This study is designed to provide important and timely insight into the management of acute stroke patients who are on new oral anticoagulants.

Learn more about the ARAMIS trial or call the Clinical Trials Office at 484-628-8585.

PROSPER

Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research

Investigator: Karen Hoerst, MD

Learn more about the PROSPER trial or call the Clinical Trials Office at 484-628-8585.

Orthopedics

Hip Fracture

REGAIN

A Randomized Controlled Trial of Regional Versus General Anesthesia for Promoting Independence After Hip Fracture

Investigator: Karen Troxell, MD

The purpose of this study is to determine whether spinal anesthesia, when used as a primary anesthetic technique for hip fracture surgery is associated with improved functional recovery and decreased risk of adverse postoperative outcomes compared to general anesthesia.

Learn more about the REGAIN trial or call the Clinical Trials Office at 484-628-8585.

Women's Health

HPV

Pap Screens & HPV

Longitudinal Clinical Evaluation of the HPV Assay on the BD Viper LT System with Cervical Specimens

Investigator: Stephen Fehnel, MD

This study collects cervical specimens to test for HPV using an experimental test. These test results will then be compared to the current standards of testing for HPV and diagnosing cervical disease. This study is enrolling by invitation only.

Learn more about the Pap Screens & HPV trial or call the Clinical Trials Office at 484-628-8585.


Uterine Fibroids

Elagolix & Heavy Menstrual Bleeding

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding associated with Uterine Fibroids in Premenopausal Women

Investigator: Stephen Fehnel, MD

This study seeks to evaluate the efficacy, safety and tolerability of the drug elagolix alone and in combination with estradiol/norethindrone acetate or placebo for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Learn more about the Elagolix trial or call the Clinical Trials Office at 484-628-8585.